The DOI matches its Crossref record.
R acing T o I nvest? T he D ynamics of C ompetition in E thical D rug D iscovery
Abstract
Recent advances in the theoretical literature have greatly expanded our understanding of the forces that shape the competitive dynamics of research and development, but a paucity of sufficiently detailed empirical data has left these insights relatively untested. We draw on unusually detailed qualitative and quantitative infernal data provided at the research program level by 10 major pharmaceutical firms to explore the usefulness of the modern literature as a source of insight into the dynamics of competition in ethical drug discovery. Our analysis focuses on one particularly compelling aspect of the literature: the suggestion that in “winner take all situations,” competition in R&D becomes a Prisoner's Dilemma, leading to overinvestment in research. Without adequate measures of the social return to innovation, we can say nothing about whether there is “too much” or “too little” research undertaken by the industry, but our results do not support the suggestion that R&D investment in drug discovery is driven by the “tit‐for‐tat” or simple reaction function models hinted at by the institutional literature. First, R&D investment is only weakly correlated across firms once common responses to exogenous shocks are accounted far, and second, rivals' R&D results are positively correlated with own research productivity, which we interpret as evidence for extensive R&D spillovers rather than the depletion externality implied by “winner take all” models. These results are not, of themselves, sufficient to reject the hypothesis that investment behavior in the industry is driven by strategic considerations since there is theoretical support for a wide variety of observable behavior as equilibrium outcomes of strategic interaction. Nonetheless, they suggest that the more extreme forms of rent dissipation identified in the literature are probably poor characterizations of the reality of competition in pharmaceuticals. Our results point both to the need to develop theories that incorporate richer models of possible payoff structures, adjustment costs, and firm heterogeneity and to the need to collect empirical data that is comprehensive enough to enable one to test them.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Measuring Competence? Exploring Firm Effects in Pharmaceutical Research
Henderson, R., & Cockburn, I. (1994) · Strategic Management Journal · doi:10.1002/smj.4250150906 · Cited by 2,622
Self-citationThe determinants of national innovative capacity
Furman, J. L., Porter, M. E., & Stern, S. (2002) · Research Policy · doi:10.1016/s0048-7333(01)00152-4 · Cited by 2,332
Identifying Technology Spillovers and Product Market Rivalry
(2013) · Econometrica · doi:10.3982/ecta9466 · Cited by 1,758
Carbon Taxes, Path Dependency, and Directed Technical Change: Evidence from the Auto Industry
Aghion, P., Dechezleprêtre, A., Hémous, D., Martin, R., & Van Reenen, J. (2016) · Journal of Political Economy · doi:10.1086/684581 · Cited by 1,604
Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery
Cockburn, I. M., & Henderson, R. M. (1998) · The Journal of Industrial Economics · doi:10.1111/1467-6451.00067 · Cited by 1,197
Self-citation
Metadata
- Authors
- Cockburn, I., & Henderson, R.
- Venue
- Journal of Economics & Management Strategy
- Publisher
- Wiley
- Published
- 1994-09
- Volume
- 3
- Issue
- 3
- Pages
- 481-519
- ISSN
- 1058-6407 (ISSN-L)
- 1530-9134
- OpenAlex
- W2167996633
- Cited by
- 225
- References
- 0
- FWCI
- 11.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: R acing T o I nvest? T he D ynamics of C ompetition in E thical D rug D iscovery. https://app.cochat.ai/papers/10.1111/j.1430-9134.1994.00481.x
- The paper
- Cockburn, I., & Henderson, R. (1994). R acing T o I nvest? T he D ynamics of C ompetition in E thical D rug D iscovery. Journal of Economics & Management Strategy. https://doi.org/10.1111/j.1430-9134.1994.00481.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.